Updated prostate cancer guidelines reflect the importance of tumor genetic testing and genomically-informed disease management.
Among the updates are expanded treatment options, including a recently approved immunotherapy regimen for locally advanced or metastatic disease.
The revised version focuses on the first-line use of immunotherapy and the measurement of tumor cells expressing PD-L1.
Experts shared the challenges they've encountered in integrating novel treatments such as CAR T-cell therapy into practice at the 2019 NCCN Annual Conference.
Research published in Cancer evaluated whether colorectal cancers diagnosed in early adulthood differ from those diagnosed at older ages.
Cancer Network speaks with Peter Ruvolo, PhD, about his work investigating the role of microenvironments in cancer and treatment resistance.
Two new studies found that targeting the cyclin-dependent kinases 4/6 exposed a vulnerability in SMARCA4-deficient cancers.
Cancer Network spoke with Curtis Pickering, PhD, about prognostic gene expression signatures for HPV-positive oropharyngeal and cervical cancers.
A recent study identified a new biomarker in colorectal cancers that may assist in early detection of the disease.
Cancer Network speaks with Eduardo Eyras, PhD about the emerging roles of RNA splicing variants in cancer treatment.